We invest across the healthcare continuum – from biotechnology breakthroughs to modern care delivery infrastructure – with a focus on improving access, outcomes, and affordability.
Biotech platforms addressing oncology, neurology, and rare diseases
Ambulatory surgery centers, specialty hospitals, and telehealth platforms
AI diagnostics, remote monitoring, and healthcare data interoperability
Our portfolio companies have collectively improved patient access to care for 2.3 million people and reduced treatment costs by an average of 22% across therapeutic areas.
Innovative Private Markets Asset Management Focused on Energy, Technology, Real Estate, Healthcare, and Government Contracting
